BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Shahcheraghi SH, Tchokonte-Nana V, Lotfi M, Lotfi M, Ghorbani A, Sadeghnia HR. Wnt/beta-catenin and PI3K/Akt/mTOR Signaling Pathways in Glioblastoma: Two Main Targets for Drug Design: A Review. Curr Pharm Des 2020;26:1729-41. [PMID: 32003685 DOI: 10.2174/1381612826666200131100630] [Cited by in Crossref: 32] [Cited by in F6Publishing: 35] [Article Influence: 10.7] [Reference Citation Analysis]
Number Citing Articles
1 Sun J, Wang J, Li M, Li S, Li H, Lu Y, Li F, Xin T, Jin F. circTOP2A functions as a ceRNA to promote glioma progression by upregulating RPN2. Cancer Sci 2023;114:490-503. [PMID: 36227125 DOI: 10.1111/cas.15612] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
2 Huang K, Xu H, Han L, Xu R, Xu Z, Xie Y. Identification of therapeutic targets and prognostic biomarkers among frizzled family genes in glioma. Front Mol Biosci 2022;9:1054614. [PMID: 36699699 DOI: 10.3389/fmolb.2022.1054614] [Reference Citation Analysis]
3 Nasrolahi A, Azizidoost S, Radoszkiewicz K, Najafi S, Ghaedrahmati F, Anbiyaee O, Khoshnam SE, Farzaneh M, Uddin S. Signaling pathways governing glioma cancer stem cells behavior. Cellular Signalling 2023;101:110493. [DOI: 10.1016/j.cellsig.2022.110493] [Reference Citation Analysis]
4 Xu X, Liang Y, Gareev I, Liang Y, Liu R, Wang N, Yang G. LncRNA as potential biomarker and therapeutic target in glioma. Mol Biol Rep 2023;50:841-51. [PMID: 36331751 DOI: 10.1007/s11033-022-08056-y] [Reference Citation Analysis]
5 Tang N, Zhu K, Jiang C, Xiong Z, Wang Q, Li J, Xu W. RNF7 promotes glioma growth via the PI3K/AKT signalling axis. J Cell Mol Med 2023;27:277-86. [PMID: 36578229 DOI: 10.1111/jcmm.17656] [Reference Citation Analysis]
6 Huang G, Wu Y, Du Y, Gan H, Hao S. Methyl-CpG Binding Protein 2 as a Potential Diagnostic and Prognostic Marker Facilitates Glioma Progression Through Activation of Wnt/β-Catenin Pathway. World Neurosurg 2022:S1878-8750(22)01767-3. [PMID: 36529430 DOI: 10.1016/j.wneu.2022.12.063] [Reference Citation Analysis]
7 Silva R, Ferreira D, Rodrigues LR. Exosome-based delivery of RNAi leads to breast cancer inhibition. Journal of Drug Delivery Science and Technology 2022. [DOI: 10.1016/j.jddst.2022.103931] [Reference Citation Analysis]
8 Liu D, Liu M, Zhang S, Shang Y, Song F, Zhang H, Du G, Wang Y. Chrysomycin A Inhibits the Proliferation, Migration and Invasion of U251 and U87-MG Glioblastoma Cells to Exert Its Anti-Cancer Effects. Molecules 2022;27:6148. [DOI: 10.3390/molecules27196148] [Reference Citation Analysis]
9 Liu Y, Li S, Chen R, Chen J, Xiao B, Lu Y, Liu J. BTBD10 inhibits glioma tumorigenesis by downregulating cyclin D1 and p-Akt. Open Life Sci 2022;17:907-16. [PMID: 36045715 DOI: 10.1515/biol-2022-0103] [Reference Citation Analysis]
10 Wu Y, Zhang Y, Li M, Yang W, Cheng L. The In Vitro Effect of Psoralen on Glioma Based on Network Pharmacology and Potential Target Research. Evidence-Based Complementary and Alternative Medicine 2022;2022:1-10. [DOI: 10.1155/2022/1952891] [Reference Citation Analysis]
11 Zhang G, Tao X, Ji B, Gong J, Ciriolo MR. Hypoxia-Driven M2-Polarized Macrophages Facilitate Cancer Aggressiveness and Temozolomide Resistance in Glioblastoma. Oxidative Medicine and Cellular Longevity 2022;2022:1-20. [DOI: 10.1155/2022/1614336] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
12 Hermawan A, Wulandari F, Hanif N, Utomo RY, Jenie RI, Ikawati M, Tafrihani AS. Identification of potential targets of the curcumin analog CCA-1.1 for glioblastoma treatment : integrated computational analysis and in vitro study. Sci Rep 2022;12:13928. [PMID: 35977996 DOI: 10.1038/s41598-022-18348-9] [Reference Citation Analysis]
13 Yang J, Chen J, Liu S, Chen R. Contribution of the Testosterone Androgen Receptor–PARD3B Signaling Axis to Tumorigenesis and Malignance of Glioblastoma Multiforme through Stimulating Cell Proliferation and Colony Formation. JCM 2022;11:4818. [DOI: 10.3390/jcm11164818] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
14 Ye C, Wei M, Huang H, Wang Y, Zhang L, Yang C, Huang Y, Luo J. Nitazoxanide inhibits osteosarcoma cells growth and metastasis by suppressing AKT/mTOR and Wnt/β-catenin signaling pathways. Biol Chem 2022. [PMID: 35946850 DOI: 10.1515/hsz-2022-0148] [Reference Citation Analysis]
15 Han Z, Mou Z, Jing Y, Jiang R, Sun T. EMX1 functions as a tumor inhibitor in spinal cord glioma through transcriptional suppression of WASF2 and inactivation of the Wnt/β-catenin axis. Brain Behav 2022;:e2684. [PMID: 35849030 DOI: 10.1002/brb3.2684] [Reference Citation Analysis]
16 Du J, Li Y, Su Y, Zhi W, Zhang J, Zhang C, Wang J, Deng W, Zhao S. LncRNA Pnky Positively Regulates Neural Stem Cell Migration by Modulating mRNA Splicing and Export of Target Genes. Cell Mol Neurobiol 2022. [PMID: 35748966 DOI: 10.1007/s10571-022-01241-4] [Reference Citation Analysis]
17 da Costa BHB, Becker AP, Neder L, Gonçalves PG, de Oliveira C, Polverini AD, Clara CA, Teixeira GR, Reis RM, Bidinotto LT. EGFL7 expression profile in IDH-wildtype glioblastomas is associated with poor patient outcome. J Pathol Transl Med 2022. [PMID: 35698739 DOI: 10.4132/jptm.2022.04.22] [Reference Citation Analysis]
18 Gupta K, Jones JC, Farias VA, Mackeyev Y, Singh PK, Quiñones-Hinojosa A, Krishnan S. Identification of Synergistic Drug Combinations to Target KRAS-Driven Chemoradioresistant Cancers Utilizing Tumoroid Models of Colorectal Adenocarcinoma and Recurrent Glioblastoma. Front Oncol 2022;12:840241. [PMID: 35664781 DOI: 10.3389/fonc.2022.840241] [Reference Citation Analysis]
19 Wu T, Chen Y, Yang L, Wang X, Chen K, Xu D. Ribonuclease A Family Member 2 Promotes the Malignant Progression of Glioma Through the PI3K/Akt Signaling Pathway. Front Oncol 2022;12:921083. [DOI: 10.3389/fonc.2022.921083] [Reference Citation Analysis]
20 Daisy Precilla S, Biswas I, Kuduvalli SS, Anitha TS. Crosstalk between PI3K/AKT/mTOR and WNT/β-Catenin signaling in GBM - Could combination therapy checkmate the collusion? Cell Signal 2022;:110350. [PMID: 35525406 DOI: 10.1016/j.cellsig.2022.110350] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
21 da S Soares R, de S Laurentino T, da Silva CT, Gonçalves JD, Lerario AM, Marie SKN, Oba-Shinjo SM, Jasiulionis MG. Cellular Model of Malignant Transformation of Primary Human Astrocytes Induced by Deadhesion/Readhesion Cycles. Int J Mol Sci 2022;23:4471. [PMID: 35562862 DOI: 10.3390/ijms23094471] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
22 Wang J, Quan Y, Lv J, Gong S, Ren P. Inhibition of FAM83D displays antitumor effects in glioblastoma via down-regulation of the AKT/Wnt/β-catenin pathway. Environ Toxicol 2022. [PMID: 35150198 DOI: 10.1002/tox.23488] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
23 Ma S, Guo Z, Wang B, Yang M, Yuan X, Ji B, Wu Y, Chen S. A Computational Framework to Identify Biomarkers for Glioma Recurrence and Potential Drugs Targeting Them. Front Genet 2022;12:832627. [DOI: 10.3389/fgene.2021.832627] [Reference Citation Analysis]
24 Sun R, Kim AH. The multifaceted mechanisms of malignant glioblastoma progression and clinical implications. Cancer Metastasis Rev 2022;41:871-98. [PMID: 35920986 DOI: 10.1007/s10555-022-10051-5] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
25 Li G, Zhong Y, Wang W, Jia X, Zhu H, Jiang W, Song Y, Xu W, Wu S. Sempervirine Mediates Autophagy and Apoptosis via the Akt/mTOR Signaling Pathways in Glioma Cells. Front Pharmacol 2021;12:770667. [PMID: 34916946 DOI: 10.3389/fphar.2021.770667] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
26 Yang L, Du C, Chen H, Diao Z. Downregulation of Williams syndrome transcription factor (WSTF) suppresses glioblastoma cell growth and invasion by inhibiting PI3K/AKT signal pathway. Eur J Histochem 2021;65. [PMID: 34784707 DOI: 10.4081/ejh.2021.3255] [Reference Citation Analysis]
27 Noronha C, Ribeiro AS, Taipa R, Castro DS, Reis J, Faria C, Paredes J. Cadherin Expression and EMT: A Focus on Gliomas. Biomedicines 2021;9:1328. [PMID: 34680444 DOI: 10.3390/biomedicines9101328] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
28 Chou FJ, Liu Y, Lang F, Yang C. D-2-Hydroxyglutarate in Glioma Biology. Cells 2021;10:2345. [PMID: 34571995 DOI: 10.3390/cells10092345] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
29 Wang J, Xia X, Tao X, Zhao P, Deng C. Knockdown of carbohydrate sulfotransferase 12 decreases the proliferation and mobility of glioblastoma cells via the WNT/β-catenin pathway. Bioengineered 2021;12:3934-46. [PMID: 34288811 DOI: 10.1080/21655979.2021.1944455] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
30 Singh N. Role of mammalian long non-coding RNAs in normal and neuro oncological disorders. Genomics 2021;113:3250-73. [PMID: 34302945 DOI: 10.1016/j.ygeno.2021.07.015] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
31 Brlek P, Kafka A, Bukovac A, Pećina-Šlaus N. Integrative cBioPortal Analysis Revealed Molecular Mechanisms That Regulate EGFR-PI3K-AKT-mTOR Pathway in Diffuse Gliomas of the Brain. Cancers (Basel) 2021;13:3247. [PMID: 34209611 DOI: 10.3390/cancers13133247] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
32 Yu L, Wei J, Liu P. Attacking the PI3K/Akt/mTOR signaling pathway for targeted therapeutic treatment in human cancer. Semin Cancer Biol 2021:S1044-579X(21)00188-7. [PMID: 34175443 DOI: 10.1016/j.semcancer.2021.06.019] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 9.5] [Reference Citation Analysis]
33 Ni H, Zhi R, Zuo J, Liu W, Xie P, Zhi Z. Pseudogene ANXA2P2 knockdown shows tumor-suppressive function by inhibition of the PI3K/PKB pathway in glioblastoma cells. J Biochem Mol Toxicol 2021;35:e22824. [PMID: 34047431 DOI: 10.1002/jbt.22824] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
34 Chelliah SS, Paul EAL, Kamarudin MNA, Parhar I. Challenges and Perspectives of Standard Therapy and Drug Development in High-Grade Gliomas. Molecules 2021;26:1169. [PMID: 33671796 DOI: 10.3390/molecules26041169] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
35 Lorzadeh S, Kohan L, Ghavami S, Azarpira N. Autophagy and the Wnt signaling pathway: A focus on Wnt/β-catenin signaling. Biochim Biophys Acta Mol Cell Res 2021;1868:118926. [PMID: 33316295 DOI: 10.1016/j.bbamcr.2020.118926] [Cited by in Crossref: 39] [Cited by in F6Publishing: 44] [Article Influence: 13.0] [Reference Citation Analysis]
36 Geng Y, Zuo P, Li XO, Zhang L. PODNL1 promotes cell proliferation and migration in glioma via regulating Akt/mTOR pathway. J Cancer 2020;11:6234-42. [PMID: 33033506 DOI: 10.7150/jca.46901] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
37 Bagherian A, Mardani R, Roudi B, Taghizadeh M, Banfshe HR, Ghaderi A, Davoodvandi A, Shamollaghamsari S, Hamblin MR, Mirzaei H. Combination Therapy with Nanomicellar-Curcumin and Temozolomide for In Vitro Therapy of Glioblastoma Multiforme via Wnt Signaling Pathways. J Mol Neurosci 2020;70:1471-83. [PMID: 32666415 DOI: 10.1007/s12031-020-01639-z] [Cited by in Crossref: 33] [Cited by in F6Publishing: 30] [Article Influence: 11.0] [Reference Citation Analysis]
38 Wuputra K, Ku CC, Wu DC, Lin YC, Saito S, Yokoyama KK. Prevention of tumor risk associated with the reprogramming of human pluripotent stem cells. J Exp Clin Cancer Res 2020;39:100. [PMID: 32493501 DOI: 10.1186/s13046-020-01584-0] [Cited by in Crossref: 26] [Cited by in F6Publishing: 27] [Article Influence: 8.7] [Reference Citation Analysis]
39 Iacobas DA, Iacobas S, Stout RF, Spray DC. Cellular Environment Remodels the Genomic Fabrics of Functional Pathways in Astrocytes. Genes (Basel). 2020;11. [PMID: 32392822 DOI: 10.3390/genes11050520] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]